IL-2 shows potential to cure some kidney and skin cancers
Researchers report that interleukin-2 may trigger immune responses to fight certain cancers, with remission seen in nine of 134 skin cancer patients and 10 of 149 kidney cancer patients. About 5 percent of 283 patients were followed, noting serious toxic side effects and past controversies from 1980s trials.
MENTIONED IN THIS ARTICLE
Chicago
Sts Seller
Cinet
The
Journal of the American Medical Association
Rosenberg
National Cancer Institute
Aspirin Cuts Stroke Risk in High Risk Patients Study Finds
A three year national study involving 15 centers including the University of Arizona shows aspirin can match warfarin for about one third of atrial fibrillation patients at high stroke risk. Younger healthier patients without prior stroke or high blood pressure may benefit with lower bleeding risk and cost. Doctors say physician guidance remains essential for treatment choice.
MENTIONED IN THIS ARTICLE
Tucson
University of Arizona
William Feinberg
Feinberg
The
Lancet
Also Mentioned on This Page
Cooper
Davenport
Iowa
STS Foundation
Europe
USA
U.S
Ry ‘ A Or
Chapin
McDowell
Tech Ave
Fwy
Rel
Loum Basile
Naturesay
Ene
ISA
Thomas Rd
Shaw Peak
Country Club & Southern
West Bell RD
W. Bell Rd
W. Warner
Indian Bend
Saturda